Startup-149

Startup-149

Lissabon, Portugal
Endobios is developing ENB-00X, early preclinical drug candidate (small molecule) to treat epilepsy and neuropathic pain.
Also, our “Explorer platform” is an untargeted discovery tool to find new therapeutic uses for small molecules